• Published in BMJ Innovations

  • Collaborator: AstraZeneca

  • Authors: Yeoman G, Furlong P, Seres M, Binder H, Chung H, Garzya V, Jones R

Patient engagement is an essential aspect in the research/development of biopharmaceutical products
and disease management. Patient centricity should be defined as ‘Putting the patient first in an open and
sustained engagement of the patient to respectfully and compassionately achieve the best experience and
outcome for that person and their family’. Important principles for patients focused on education/information,
cocreation, access and transparency. The development of a consistent definition of patient centricity and its
associated principles provides an opportunity for biopharmaceutical companies to adopt and use these as a
reference point for consistent patient engagement throughout the product life cycle.